I'm getting a bit tired of posting to myself. Why is there no interest in this stock? I'll answer that tomorrow when I answer my own post. Meanwhile.... the medical reporter for the Wall St. Journal (name forgotten) had some very complimentary things to say about AHP today on CNBC. AHP, apparently, has a new drug to combat ear infections in children which will have no competition in the drug marketplace. He also had some other lauditory things to say about AHP pipeline, but I was in another room and didn't catch the names of the products. He also said that Embrel (spelling?) is a success. Overall, a very bullish outlook on this rather backburner drug stock.
Best Of |
Favorites & Replies |
Start a New Board |
My Fool |
BATS data provided in real-time. NYSE, NASDAQ and NYSEMKT data delayed 15 minutes.
Real-Time prices provided by BATS. Market data provided by Interactive Data.
Company fundamental data provided by Morningstar. Earnings Estimates, Analyst Rat